UA70334C2 - BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS - Google Patents

BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS Download PDF

Info

Publication number: UA70334C2
Authority: UA; Ukraine
Prior art keywords: formula; сно; alkyl; compounds; compound according
Prior art date: 1998-10-06

Application number

UA2001031998A

Other languages

English (en)

Ukrainian (uk)

Inventor

Ludo Edmond Josephine K Kennis

Original Assignee

Janssen Pharmaceutica N V Jans

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-06

Filing date

1999-01-10

Publication date

2004-10-15

1999-01-10 Application filed by Janssen Pharmaceutica N V Jans filed Critical Janssen Pharmaceutica N V Jans

2004-10-15 Publication of UA70334C2 publication Critical patent/UA70334C2/uk

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

UA2001031998A 1998-10-06 1999-01-10 BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS UA70334C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203363		1998-10-06
PCT/EP1999/007418 WO2000020422A1 (en)	1998-10-06	1999-10-01	BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS

Publications (1)

Publication Number	Publication Date
UA70334C2 true UA70334C2 (en)	2004-10-15

Family

ID=8234188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2001031998A UA70334C2 (en)	1998-10-06	1999-01-10	BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS

Country Status (27)

Country	Link
US (2)	US6426350B1 (de)
EP (1)	EP1117667B1 (de)
JP (1)	JP4580555B2 (de)
KR (1)	KR20010071828A (de)
CN (1)	CN1158287C (de)
AR (1)	AR023678A1 (de)
AT (1)	ATE363485T1 (de)
AU (1)	AU760226B2 (de)
BG (1)	BG64625B1 (de)
BR (1)	BR9913110A (de)
CA (1)	CA2346084C (de)
CZ (1)	CZ20011103A3 (de)
DE (1)	DE69936219T2 (de)
EE (1)	EE04835B1 (de)
ES (1)	ES2288025T3 (de)
HU (1)	HUP0103612A3 (de)
ID (1)	ID28280A (de)
IL (2)	IL142442A0 (de)
NO (1)	NO20011309L (de)
NZ (1)	NZ509911A (de)
PL (1)	PL347184A1 (de)
RU (1)	RU2222542C2 (de)
SK (1)	SK4312001A3 (de)
TR (1)	TR200100954T2 (de)
TW (1)	TWI251595B (de)
UA (1)	UA70334C2 (de)
WO (1)	WO2000020422A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003219029B2 (en) *	2002-03-08	2008-09-11	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V	Use of EGFR transactivation inhibitors in human cancer
ATE521593T1 (de) *	2002-04-03	2011-09-15	Orion Corp	Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen
CN1972938B (zh)	2004-04-12	2010-09-29	大正制药株式会社	环状胺化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3752820A (en) *	1972-03-20	1973-08-14	Colgate Palmolive Co	Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) *	1984-09-27	1987-05-22	Synthelabo	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) *	1985-09-03	1987-08-11	Merck & Co., Inc.	Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (de) *	1988-04-27	1991-03-20	Glaxo Group Limited	Laktam-Derivate
US5100891A (en) *	1991-01-18	1992-03-31	Hoechst-Roussel Pharmaceuticals Inc.	Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB9106179D0 (en) *	1991-03-22	1991-05-08	Sandoz Ltd	Improvements in or relating to organic compounds
DE69531476T2 (de) *	1994-09-12	2004-06-09	Lilly Industries Ltd., Basingstoke	Serotonergische Modulatoren
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
UA52681C2 (uk)	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en not_active Ceased
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-01 EP EP99947469A patent/EP1117667B1/de not_active Expired - Lifetime
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko not_active Ceased
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309L/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BR9913110A (pt)	2001-05-08
EE04835B1 (et)	2007-06-15
RU2222542C2 (ru)	2004-01-27
HUP0103612A2 (hu)	2002-01-28
NZ509911A (en)	2002-09-27
AU760226B2 (en)	2003-05-08
KR20010071828A (ko)	2001-07-31
JP2002526546A (ja)	2002-08-20
AR023678A1 (es)	2002-09-04
ID28280A (id)	2001-05-10
US6774129B2 (en)	2004-08-10
HUP0103612A3 (en)	2003-03-28
HK1039113A1 (en)	2002-04-12
BG105331A (en)	2001-11-30
NO20011309D0 (no)	2001-03-15
ATE363485T1 (de)	2007-06-15
ES2288025T3 (es)	2007-12-16
PL347184A1 (en)	2002-03-25
EP1117667B1 (de)	2007-05-30
SK4312001A3 (en)	2001-12-03
CA2346084A1 (en)	2000-04-13
BG64625B1 (bg)	2005-09-30
NO20011309L (no)	2001-03-15
CN1158287C (zh)	2004-07-21
IL142442A (en)	2006-10-05
DE69936219D1 (de)	2007-07-12
IL142442A0 (en)	2002-03-10
DE69936219T2 (de)	2008-02-07
CZ20011103A3 (cs)	2001-12-12
EP1117667A1 (de)	2001-07-25
AU6089999A (en)	2000-04-26
JP4580555B2 (ja)	2010-11-17
US6426350B1 (en)	2002-07-30
TR200100954T2 (tr)	2001-12-21
EE200100206A (et)	2002-06-17
TWI251595B (en)	2006-03-21
WO2000020422A1 (en)	2000-04-13
US20020169178A1 (en)	2002-11-14
CA2346084C (en)	2010-01-26
CN1321159A (zh)	2001-11-07

Publication	Publication Date	Title
EP4699607A2 (de)	2026-02-25	N-(hydroxyalkyl(hetero)aryl)tetrahydrofurancarboxamide als modulatoren von natriumkanälen
US12421249B2 (en)	2025-09-23	Inhibitors of APOL1 and methods of using same
ES2540976T3 (es)	2015-07-15	Nuevos derivados de 6,11-dihidro-5H-benzo[d]imidazo[1,2-a]acepinas usados como ligandos del receptor de la histamina H4
CZ43399A3 (cs)	1999-07-14	Etheroví muskarinní antagonisté
CA2776028A1 (en)	2011-04-21	Pyrrolo[2,3-d]pyrimidine compounds
SA98190402B1 (ar)	2006-08-20	تركيب متعدد الشكل البللوري لمضاد مستقبل التاكيكين
UA112558C2 (uk)	2016-09-26	Похідні дигідробензооксазину та дигідропіридооксазину
KR20080095885A (ko)	2008-10-29	벤젠설포닐-크로만, 티오크로만, 테트라하이드로나프탈렌 및 관련된 감마 세크라타제 억제제
UA52681C2 (uk)	2003-01-15	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
AU2008276492A2 (en)	2010-02-18	Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
SK153298A3 (en)	1999-03-12	Alkylaminobenzothiazole and -benzoxazole derivatives
JP2025516005A (ja)	2025-05-23	疼痛の処置のためのｎａｖ１．８の二環式複素環アミド阻害剤
KR20000016151A (ko)	2000-03-25	벤족사지논 도파민 d4 수용체 길항제
IT8148772A1 (it)	1982-12-26	Derivato di piperazina, procedimento per prepararlo e composizione analgesica che lo contiene
UA69420C2 (uk)	2004-09-15	ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en)	2004-10-15	BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
UA71938C2 (en)	2005-01-17	BENZYOXAZOLES AND PHENONES AS a2-ANTAGONISTS
OA21895A (en)	2025-06-20	N-(HydroxyalkyI (Hetero) Aryl) Tetrahydrofuran carboxamides as modulators of sodium channels.
OA21175A (en)	2024-02-02	Inhibitors of APOL1 and methods of using same.
MXPA01003514A (en)	2001-12-04	BENZOTHIENO[3,2-c]PYRIDINES AS&agr;2
OA21241A (en)	2024-03-18	Substituted tetrahydrofurans as modulators of sodium channels.
HK1039113B (en)	2007-07-20	Benzothieno[3,2-c]pyridines as alpha2 antagonists
HK1178887A1 (en)	2013-09-19	2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists